Wikidata

(Q27851553)

English

Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

title
Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer (English)
1 reference
stated in
PubMed
PubMed publication ID
20142587
retrieved
13 November 2016
author name string
Harold J Burstein
series ordinal
1
0 references
Yan Sun
series ordinal
2
0 references
Luc Y Dirix
series ordinal
3
0 references
Zefei Jiang
series ordinal
4
0 references
Robert Paridaens
series ordinal
5
0 references
Antoinette R Tan
series ordinal
6
0 references
Ahmad Awada
series ordinal
7
0 references
Anantbhushan Ranade
series ordinal
8
0 references
Shunchang Jiao
series ordinal
9
0 references
Gary Schwartz
series ordinal
10
0 references
Richat Abbas
series ordinal
11
0 references
Christine Powell
series ordinal
12
0 references
Kathleen Turnbull
series ordinal
13
0 references
Jennifer Vermette
series ordinal
14
0 references
Charles Zacharchuk
series ordinal
15
0 references
Rajendra Badwe
series ordinal
16
0 references
publication date
10 March 2010
0 references
volume
28
0 references
issue
8
0 references
page(s)
1301-7
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q27851553&oldid=1977857215"